Days after Delhi Lt Governor VK Saxena referred a matter pertaining to drugs failing quality standard tests to CBI, Raj Niwas officials on Wednesday reported another medicine used for treating seizures and epilepsy turning out to be spurious.
Mr Saxena had last week recommended a CBI inquiry into the alleged supply of drugs that "failed quality standard tests" and have the "potential of endangering lives."
According to officials, another drug sample taken from Delhi government hospitals was failed by the RDTL, or Regional Drug Testing Laboratory, in Chandigarh.
This time an anti-epilepsy drug called 'Sodium Valproate' was found to be falling short of the standards.
The report was issued by a government analyst on December 22, an official said.
The drugs that have been found to be of "sub-standard quality" included Cephalexin, a critical life-saving antibiotic used for the treatment of lung and urinary tract infections, according to officials.
They also included Dexamethasone, a steroid used for curing life-threatening inflammation in lungs, joints, and swelling in the body, anti-epilepsy and anti-anxiety psychiatric drug Levetiracetam, and anti-hypertension drug Amlodipine, they said.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Featured Video Of The Day
Tihar Inmate Dies Of 'Drug Overdose', Family Alleges Foul Play Russia's Firing Of ICBM On Ukraine Is Weapon's 1st Combat Use In History Amazon Employee Greets Friend At Wedding, Dies Of Cardiac Arrest Maharashtra Chief Minister Pick Contentious For Both Ruling, Opposition Camps Brazil Police Call Ex-President Bolsonaro's Indictment Over 2022 "Coup" Plot World Leaders Split As ICC Issues Arrest Warrant For Netanyahu Famous Iceland Geothermal Spa Covered In Lava Post Volcanic Eruption Track Latest News Live on NDTV.com and get news updates from India and around the world.